Advanced disease at enrollment in HIV care in four sub-saharan african countries: Change from 2006 To 2011 and multilevel predictors in 2011

AIDS

Volumn 28, Issue 16, 2014, Pages 2429-2438

  Hoffman, Susie ^a,b   Wu, Yingfeng ^b   Lahuerta, Maria ^b   Kulkarni, Sarah Gorrell ^c   Nuwagaba Biribonwoha, Harriet ^b   El Sadr, Wafaa ^b   Remien, Robert H ^a   Mugisha, Veronicah ^b   Hawken, Mark ^b   Chuva, Ema ^d   Nash, Denis ^a,b,c   Elul, Batya ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Mailman School of Public Health ^*  (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d MINISTRY OF HEALTH   (Mozambique)

Author keywords

Delayed diagnosis of HIV; HIV care; Late enrollment in care; Late entry to care; Late presentation to care; Sub Saharan Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE FACILITY; HEALTH PROGRAM; HEALTH SURVEY; HIGH RISK PATIENT; HIV CARE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; KENYA; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MOZAMBIQUE; PATIENT CARE; PATIENT EDUCATION; POINT OF CARE TESTING; PREGNANT WOMAN; RWANDA; SEX DIFFERENCE; SINGLE MAN; SINGLE WOMAN; TANZANIA; TREND STUDY; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION; AFRICA SOUTH OF THE SAHARA; DELAYED DIAGNOSIS; HIV INFECTIONS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PREGNANCY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREGNANCY; YOUNG ADULT;

EID: 84916601676     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000427     Document Type: Article

References (39)

1. Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C, et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007;12:89-96.
2. Smit C, Hallett TB, Lange J, Garnett G, de Wolf F. Late entry to HIV care limits the impact of antiretroviral therapy in The Netherlands. PLoS One 2008;3:e1949.
3. Metsch LR, Pereyra M, Messinger S, del Rio C, Strathdee SA, Anderson-Mahoney P, et al. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis 2008;47:577-584.
4. Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
5. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, Kerr T, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376:532-539.
6. Das M, Chu PL, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010;5:e11068.
7. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013;339:966-971.
8. Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010;50:1512-1520.
9. Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K, et al. Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr 2008;49:282-286.
10. Begovac J, Gedike K, Lukas D, Lepej SZ. Late presentation to care for HIV infection in Croatia and the effect of interventions during the Croatian Global Fund Project. AIDS Behav 2008;12:S48-53.
11. Gandhi NR, Skanderson M, Gordon KS, Concato J, Justice AC. Delayed presentation for human immunodeficiency virus (HIV) care among veterans: a problem of access or screening? Med Care 2007;45:1105-1109.
12. Gay CL, Napravnik S, Eron JJ Jr. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS 2006;20:775-778.
13. Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, Balzano R, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 2004;36:951-959.
14. Krawczyk CS, Funkhouser E, Kilby JM, Kaslow RA, Bey AK, Vermund SH. Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J 2006;99:472-481.
15. Ndiaye B, Salleron J, Vincent A, Bataille P, Bonnevie F, Choisy P, et al. Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. BMC Infect Dis 2011;11:11.
16. Ohl M, Tate J, Duggal M, Skanderson M, Scotch M, Kaboli P, et al. Rural residence is associated with delayed care entry and increased mortality among veterans with human immunodeficiency virus infection. Med Care 2010;48:1064-1070.
17. Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004;18:2145-2151.
18. Zoufaly A, van der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, et al. Late presentation for HIV diagnosis and care in Germany. HIV Med 2012;13:172-181.
19. Egger M. Immunodeficiency at the start of combination antiretroviral therapy in low, middle and high-income countries. J Acquir Immune Defic Syndr 2014;65:e8-16.
20. Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, Okamura M, Alvim MF, Fernandes R, et al. Factors associated with late antiretroviral therapy initiation among adults in Mozambique. PLoS One 2012;7:e37125.
21. Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni SG, Wu Y, et al. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon? J Health Care Poor Underserved 2013;24:359-383.
22. Lahuerta M, Wu Y, Hoffman S, Elul B, Kulkarni SG, Remien RH, et al. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: Findings from four sub-Saharan African countries. Clin Infect Dis 2014;58:432-441.
23. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, et al. Late-disease stage at presentation to an HIV clinicinthe era offree antiretroviral therapy insub-Saharan Africa. J Acquir Immune Defic Syndr 2009;52:280-289.
24. Nash D, Wu Y, Elul B, Hoos D, El-Sadr W, for the International Center for AIDS Care and Treatment Programs. Program-level and contextual-level determinants of low-median CD4 cell count in cohorts of persons initiating ART in eight sub-Saharan African countries. AIDS 2011;25:1523-1533.
25. Drain PK, Losina E, Parker G, Giddy J, Ross D, Katz JN, et al. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS One 2013;8:e55305.
26. Posse M, Meheus F, van Asten H, van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health 2008;13:904-913.
27. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach: 2010 revision. Geneva, Switzerland: World Health Organization; 2010.
28. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach: (2006 revision). Geneva, Switzerland: World Health Organization; 2006.
29. UNAIDS. UNAIDS AIDS epidemic update. Geneva, Switzerland: UNAIDS; 2006.
30. UNAIDS. UNAIDS report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS; 2012.
31. Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, Makumbi FE, et al. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr 2010;54:180-184.
32. Sweat M, Morin S, Celentano D, Mulawa M, Singh B, et al. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 2011;11:525-532.
33. van Rooyen H, Barnabas RV, Baeten JM, Phakathi Z, Joseph P, Krows M, et al. High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr 2013 [Epub ahead of print].
34. Marcellin F, Abe C, Loubiere S, Boyer S, Blanche J, Koulla-Shiro S, et al. Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS 2009;23:1015-1019.
35. Hatcher AM, Turan JM, Leslie HH, Kanya LW, Kwena Z, Johnson MO, et al. Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya. AIDS Behav 2012;16:1295-1307.
36. Mulissa Z, Jerene D, Lindtjorn B. Patients present earlier and survival has improved, but pre-ART attrition is high in a sixyear HIV cohort data from Ethiopia. PLoS One 2010;5:e13268.
37. Galdas PM, Cheater F, Marshall P. Men and health helpseeking behaviour: literature review. J Adv Nurs 2005;49:616-623.
38. Musheke M, Ntalasha H, Gari S, Mckenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in Sub-Saharan Africa. BMC Public Health 2013;13:220 http://www.biomedcentral.com/1471-2458/1413/1220.
39. Dawad S, Hoffman S, De Menezes ID, Mngomezulu N, Blanchard K, Stiefvater E, et al. Linkage to care: Barriers and facilitators from the perspectives of counselors and clients. Poster presentation, A-452-0310-17640. In XIX International AIDS Conference (AIDS 2012). Washington, DC; 22-27 July 2012.